Effective treatment for acute ischemic stroke has been available for 17 years, but wide geographic variability remains in timely access to neurologic expertise and other components of stroke systems of care. Telemedical technology can be used to improve such access, but it is debatable whether neurologists have an ethical obligation to provide consultation regarding tissue plasminogen activator use via the telephone. This article examines whether neurologists are ethically obligated to provide telephone-mediated acute stroke consultation.
Address correspondence to Dr Justin A. Sattin, Department of Neurology, 1685 Highland Ave, Madison, WI 53711, firstname.lastname@example.org.
Relationship Disclosure: Dr Sattin reports no disclosure.
Unlabeled Use of Products/Investigational Use Disclosure: Dr Sattin reports no disclosure.